Hit Generation
Hit Generation is a methodological contribution in de novo drug design that identifies novel chemical compounds with desired biological activity through computational or experimental screening, distinguished from other approaches by its focus on discovering initial active candidates (hits) prior to optimization.
41
Publications
2K
Citations
340
Authors
62
Institutions
Publications per year
2017–2026
14
Parents
41
ChemGPS-NP: Tuned for Navigation in Biologically Relevant Chemical Space
Josefin Larsson, Johan Gottfries, Sorel Mureşan et al. · Journal of Natural Products · 2007 · 210 citations
In Silico ADMET Traffic Lights as a Tool for the Prioritization of HTS Hits
Mario Lobell, Martin Hendrix, Berthold Hinzen et al. · ChemMedChem · 2006 · 113 citations
1–5 of 41
340
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 340
62
Novartis (Switzerland)
Basel, Switzerland
4 h-index
27 publications
930 citations
Janssen (United States)
Hopewell, United States
3 h-index
6 publications
197 citations
Genomics Institute of the Novartis Research Foundation
San Diego, United States
3 h-index
9 publications
377 citations
Novartis Institutes for BioMedical Research
Basel, Switzerland
2 h-index
20 publications
564 citations
AstraZeneca (Sweden)
Södertälje, Sweden
2 h-index
7 publications
876 citations
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
2 h-index
8 publications
96 citations

Janssen (Belgium)
Beerse, Belgium
2 h-index
32 publications
1.8K citations
Springhouse
Boston, United States
2 h-index
2 publications
97 citations
1–8 of 62
9 publications · 488 citations
9
h-index
3 publications · 141 citations
3
h-index
JCIM · 1 publications · 52 citations
2
h-index
2 publications · 67 citations
2
h-index
Repository · 2 publications · 89 citations
2
h-index
1–5